Gastrointestinal Langerhans cell histiocytosis responding to cladribine and imatinib mesylate [PDF]
, 2010 Gastrointestinal involvement in Langerhans cells histiocytosis (LCH) is extremely rare. An optimal treatment regimen is not defined yet and its prognosis is relatively poor.
Agreda Vásquez, Gladys Patricia +4 more
core
Erdheim Chester disease – 25 year history with early CNS involvement [PDF]
, 2016 We report a case of Erdheim-Chester disease (ECD) with a 25-year history following initial presentation with diabetes insipidus and brainstem involvement.
Cohen, N +5 more
core +2 more sources
Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents
Journal of Clinical Periodontology, EarlyView.ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev +5 more
wiley +1 more source
Langerhans cell histiocytosis in children: a case report and brief review of the literature
PAMJ Clinical Medicine, 2019 Langerhans cell histiocytosis (LCH), formerly known as histiocytosis X, is a non-malignant disease involving clonal proliferation of Langerhans cells. It is an orphan disease affecting mainly the child and the young adult.
Zakaria El Ouali +7 more
doaj +1 more source
Dermoscopy in the diagnosis of juvenile xanthogranuloma [PDF]
Anais Brasileiros de Dermatologia, 2018 : Juvenile xanthogranuloma is the most common form of non-Langerhans cell histiocytosis. It manifests clinically as a red-yellow papule, usually showing spontaneous remission. The diagnosis is based on clinical and histological findings.
Thaís Erance de Oliveira +2 more
doaj +1 more source
Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature [PDF]
, 2019 Langerhans cell histiocytosis (LCH) is a diagnostic and therapeutic challenge. We report on a rare case of its primary oral manifestation that was treated successfully with the BRAF-specific agent, vemurafenib, after insufficient standard LCH treatment ...
Beck-Broichsitter, Benedicta +8 more
core +1 more source
Gingival and Periodontal Diseases and Conditions in Children and Adolescents: Consensus Report
Journal of Clinical Periodontology, EarlyView.ABSTRACT Background The objectives of this Focused Workshop were to update the epidemiology, aetiology, risk factors, diagnosis and management of gingival and periodontal diseases and conditions in children and adolescents, and to explore the applicability of the 2018 Classification in children and adolescents.
Iain Chapple +30 more
wiley +1 more source
BMC Pediatrics, 2019 Background Juvenile xanthogranuloma (JXG) belongs to the heterogeneous group of non-Langerhans cell histiocytosis and is caused by an accumulation and proliferation of macrophages.
Michaela Höck +6 more
doaj +1 more source
A Multidisciplinary Non-Invasive Approach to Monitor Response to Intravenous Immunoglobulin Treatment in Neurodegenerative Langerhans Cell Histiocytosis: A Real-World Study. [PDF]
, 2023 Irene Trambusti +9 more
openalex +1 more source